Drugs News and Research

RSS

Bend Research expands hot-melt extrusion pharmaceutical manufacturing capabilities

Bend Research Inc., a leading independent drug-formulation development and manufacturing company, announced today that it is expanding its pharmaceutical manufacturing capabilities for hot-melt extrusion.

7 Sep 2010

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

Bruker Corporation announces a major order from the University of Maryland School of Medicine for its ultra-high field AVANCE III 950 US2 NMR spectrometer. The 950 MHz Nuclear Magnetic Resonance magnet and spectrometer will help University of Maryland researchers to unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

7 Sep 2010

IBM announces computing projects to produce clean, safe water

IBM's World Community Grid, a worldwide network of PC owners helping scientists solve humanitarian challenges, today announced several computing projects aimed at developing techniques to produce cleaner and safer water, an increasingly scarce commodity eluding at least 1.2 billion people worldwide.

7 Sep 2010

Psilocybin reduces anxiety, improves mood with advanced-stage cancer: Study

In the first human study of its kind to be published in more than 35 years, researchers found psilocybin, an hallucinogen which occurs naturally in "magic mushrooms," can safely improve the moods of patients with advanced-stage cancer and anxiety, according to an article published online today in the Archives of General Psychiatry.

7 Sep 2010

Researchers to develop new treatment strategy for cancer

Cancer is a difficult disease to treat because it's a personal disease. Each case is unique and based on a combination of environmental and genetic factors. Conventional chemotherapy employs treatment with one or more drugs, assuming that these medicines are able to both "diagnose" and "treat" the affected cells. Many of the side effects experienced by chemotherapy patients are due to the fact that the drugs they are taking aren't selective enough.

7 Sep 2010

Researchers discover new antibiotics in insect's brain

Cockroaches could be more of a health benefit than a health hazard according to scientists from the University of Nottingham, who have discovered powerful antibiotic properties in the brains of cockroaches and locusts.

7 Sep 2010

New blood signature test to diagnose, treat respiratory infections

Coughing and wheezing patients could someday benefit from quicker, more accurate diagnosis and treatment for respiratory infections such as flu, through a simple blood test, according to scientists.

7 Sep 2010

Scientists urge government to set target effectiveness for newly approved antibiotics

The United States must focus on conserving the use of antibacterial drugs, or face a public health crisis from rapidly rising rates of antibiotic-resistant infections, according to an analysis out today.

7 Sep 2010

Combined treatment may benefit early-stage schizophrenia patients: Report

Patients with early stage schizophrenia who receive a combination of medication and a psychosocial intervention appear less likely to discontinue treatment or relapse and may have improved insight, quality of life and social functioning than those taking medication alone, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

7 Sep 2010

Survey reveals lack of public awareness about radiotherapy's importance in treating cancer

Only one in ten people know that radiotherapy helps cure forty per cent of cancer patients according to new figures published by Cancer Research UK today.

7 Sep 2010

Young drug users develop brain abnormalities

According to a new study published in the Australian Medical Journal, 20 percent of users of the drugs ecstasy, ice and speed in the ER developed signs of brain damage. Two thirds had concentration and mood problems, and half said they had general health problems.

5 Sep 2010

Single-dose of experimental malaria drug clears parasites in mice, represents potential new class of drugs to treat malaria in humans

An experimental malaria drug was shown to effectively treat the disease in mice with only a single dose, according to a study published Thursday in the journal Science, Reuters reports (Kelland, 9/2). The new drug, known as NITD609, "represents an entirely new class of medicines to treat malaria ... Human trials, backed by Swiss pharmaceutical giant Novartis AG, could begin later this year," the Wall Street Journal writes (Naik, 9/3).

4 Sep 2010

Almost half of all Americans use prescription drugs each month

Nearly half of all Americans used at least one prescription drug per month in 2008, according to a study by the Centers for Disease Control and Prevention, Bloomberg reports. That's a 10 percent increase over the preceding decade. Over that time, yearly spending by Americans on drugs doubled to $234 billion. "The two biggest-sellers last year were Pfizer Inc.'s Lipitor for high cholesterol and Bristol-Myers Squibb Co.'s clot-buster, Plavix.

4 Sep 2010

IAS urges to review guidelines for implementing HIV prevention and care

Following the imprisonment of Maxim Popov in April 2010, sentenced to 7 years jail primarily for the promotion of HIV prevention efforts in Uzbekistan, the International AIDS Society (IAS) notes with alarm the detention of a medial practitioner working in HIV prevention in Ukraine.

4 Sep 2010

CMS to withdraw provisions of Medicaid pharmacy reimbursement formula under AMP rule: NACDS, NCPA

We are pleased that the Centers for Medicare & Medicaid Services has proposed a rule that would withdraw provisions of what is known as the Medicaid average manufacturer price rule. The proposed rule calls for the withdrawal of existing provisions that define AMP, that determine the calculation of federal upper limits, and that define 'multiple source drug.'

4 Sep 2010

VOA News examines U.S. Global Health Initiative

VOA News examines President Barack Obama's $63 billion Global Health Initiative (GHI), noting the initiative's emphasis on cost-effective strategies to improve child- and maternal-health as well as programs to fight HIV/AIDS, tuberculosis (TB) and malaria. The article includes recent comments by Secretary of State Hillary Rodham Clinton on the role the GHI will play in strengthening health systems and the administration's on-going commitment to global HIV/AIDS programs.

4 Sep 2010

AVAC calls for economic and political support for CAPRISA 004 microbicide trial's critical follow-up studies

AVAC today issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible. The call comes as a group of microbicide and public health experts have agreed upon a plan for further studies, which are expected to cost $100 million over three years, of which only $58 million has been committed.

4 Sep 2010

Fatty plaque in arteries increase risk for life-threatening cardiovascular events

An international study of clinical data led by a Department of Veterans Affairs-Harvard University cardiologist found that patients with deposits of fatty plaque in their arteries are at especially high risk for life-threatening cardiovascular events if they have diabetes, disease in multiple arteries or a history of heart attack or stroke.

4 Sep 2010

State News: Ohio, Florida take advantage of federal health funds; Mass. psychiatrists win court case

The Columbus Dispatch: "Gov. Ted Strickland's administration announced today that nearly $200 million in recently freed up state funds will go to Ohio hospitals, community mental health services, and a program which provides medication to low-income residents with HIV/AIDS. … The state money became available after Congress agreed to continue paying a higher share of the cost of state Medicaid programs that provide insurance coverage to the poor.

3 Sep 2010

Researchers complete INX-189 clinical trials for Hepatitis C virus

The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed.

3 Sep 2010

Drugs News and Research

Bend Research expands hot-melt extrusion pharmaceutical manufacturing capabilities

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

IBM announces computing projects to produce clean, safe water

Psilocybin reduces anxiety, improves mood with advanced-stage cancer: Study

Researchers to develop new treatment strategy for cancer

Researchers discover new antibiotics in insect's brain

New blood signature test to diagnose, treat respiratory infections

Scientists urge government to set target effectiveness for newly approved antibiotics

Combined treatment may benefit early-stage schizophrenia patients: Report

Survey reveals lack of public awareness about radiotherapy's importance in treating cancer

Young drug users develop brain abnormalities

Single-dose of experimental malaria drug clears parasites in mice, represents potential new class of drugs to treat malaria in humans

Almost half of all Americans use prescription drugs each month

IAS urges to review guidelines for implementing HIV prevention and care

CMS to withdraw provisions of Medicaid pharmacy reimbursement formula under AMP rule: NACDS, NCPA

VOA News examines U.S. Global Health Initiative

AVAC calls for economic and political support for CAPRISA 004 microbicide trial's critical follow-up studies

Fatty plaque in arteries increase risk for life-threatening cardiovascular events

State News: Ohio, Florida take advantage of federal health funds; Mass. psychiatrists win court case

Researchers complete INX-189 clinical trials for Hepatitis C virus

Drug Discovery - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News